Results 41 to 50 of about 12,222 (228)

Relationship between device acceptance and patient-reported outcomes in Left Ventricular Assist Device (LVAD) recipients

, 2020
Raw data for the article: Relationship between device acceptance and patient-reported outcomes in Left Ventricular Assist Device (LVAD) recipientsTHIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ACCESSIBLE HERE. TO VIEW A LIST OF FILES AND ACCESS THE FILES
ISMETT, D (via Mendeley Data)
core   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Left Ventricular Assist Device Implantation and Concomitant Dor Procedure: a Single Center Experience [PDF]

Brazilian Journal of Cardiovascular Surgery, 2020
Objective: Left ventricular assist device (LVAD) implantation with concomitant Dor plasty is only reported anecdotally. We herein aimed to describe our experience with LVAD and concomitant Dor procedures and describe long-term outcomes of this special ...
Andreas Schaefer, Yvonne Schneeberger, Liesa Castro, Bjoern Sill, Yousuf Alassar, Meike Rybczynski, Markus J Barten, Hanno Grahn, Hermann Reichenspurner, Sebastian A Philipp, Alexander M Bernhardt   +10 more
doaj   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Lawn Mower Versus Left Ventricular Assist Device

JACC: Case Reports, 2020
A 77-year-old man with history of ischemic cardiomyopathy and left ventricular assist device (LVAD) presented with abdominal pain after a lawn mower accident.
Vishal N. Rao, MD, MPH, Marat Fudim, MD, MHS, Andrew Griffin, MD, Jennifer A. Rymer, MD, MBA, W. Schuyler Jones, MD, Lynne M.H. Koweek, MD, Tony P. Smith, MD, Daniele Marin, MD, Adam D. DeVore, MD, MHS   +8 more
doaj   +1 more source

Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1246-1255, April 2025.
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger, Elric Zweck, Constanze Moos, Patrick Horn, Fabian Voß, Heinz‐Peter Schultheiss, Jacob Eifer Møller, Udo Boeken, Hug Aubin, Artur Lichtenberg, Malte Kelm, Michael Roden, Amin Polzin, Ralf Westenfeld, Julia Szendroedi, Daniel Scheiber   +15 more
wiley   +1 more source

Computational Simulation of Cardiac Function and Blood Flow in the Circulatory System under Continuous Flow Left Ventricular Assist Device Support during Atrial Fibrillation

Applied Sciences, 2020
Prevalence of atrial fibrillation (AF) is high in heart failure patients supported by a continuous flow left ventricular assist device (CF-LVAD); however, the long term effects remain unclear. In this study, a computational model simulating effects of AF
Selim Bozkurt
doaj   +1 more source

Sex-based considerations for implementation of ventricular assist device therapy

Frontiers in Cardiovascular Medicine, 2022
Women with advanced heart failure receive advanced surgical therapies such as durable left ventricular assist device (LVAD) implantation or heart transplantation at a rate much lower compared to males. Reasons for this discrepancy remain largely unknown.
K. Candis Jones-Ungerleider, Angela Rose, Kevin Knott, Sarah Comstock, Jonathan W. Haft, Francis D. Pagani, Paul C. Tang, Paul C. Tang   +7 more
doaj   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

Left Ventricular Assist Device (LVAD) Infections: A Single Center Experience

Graduate Medical Education Research Journal, 2019
Mentor: Uriel Sadkovsky Program: Infectious Disease Background: Infectious complications play a major role in morbidity LVAD implantation. We report the incidence of LVAD infections at our institution over 1-year period.
Rajendra Karnatak, Uriel Sadkovsky
doaj   +1 more source